Prostate-Specific Membrane Antigen Imaging Before and After 177Lu-PSMA-617 Treatment
After previously reporting effective results from 177LU-PSMA-617 treatment in patients with metastatic castration-resistant prostate cancer (mCRPC), Jones T. Nauseef, MD, PhD, sought to refine...
